Business Context and Reporting Period
This Form 8-K is a current report filed by Fluidigm Corporation (not Standard BioTools Inc.) on August 5, 2021. The filing serves to report the company's financial results for the second fiscal quarter of 2021. The registrant is incorporated in Delaware and its common stock trades on the Nasdaq Global Select Market under the symbol FLDM.
Key Financial Metrics
The provided text is a cover page and index for the 8-K filing. It references a press release (Exhibit 99.1) containing the actual financial data but does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity within this document.
Material Changes
The filing text does not provide specific data points to compare against the prior comparable period. It only indicates that results for the second fiscal quarter of 2021 were issued.
Guidance, Outlook, and Risks
The document does not include management commentary, forward-looking guidance, risk factors, or details on contingencies. It explicitly states that the information furnished, including the attached press release, is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference except as expressly set forth.
Investor Verification Checklist
- Verify the correct registrant name: The filing is for Fluidigm Corporation, not Standard BioTools Inc.
- Locate Exhibit 99.1 (the Press Release dated August 5, 2021) to obtain actual revenue, net income, and cash flow figures.
- Confirm the trading symbol FLDM on the Nasdaq Global Select Market.
- Note that this specific 8-K text does not contain the financial data itself, only the notification of its release.